Represented BCTG Acquisition Corp., a special purpose acquisition company focused on biotechnology, in its $145 million initial public offering.
-
Co-Chair Elect, Loeb & Loeb LLP; Co-Chair, Capital Markets and Corporate
-
Partner
-
Assistant Deputy Chair, Capital Markets and Corporate